Reference health
Anti-solvent co-crystallization of carbamazepine and saccharin
36/36 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 36 checked references that resolve
resolves10.1016/j.ejps.2010.08.012
Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid
resolves10.1021/cg100451q
Formation of Cocrystals from Stoichiometric Solutions of Incongruently Saturating Systems by Spray Drying
resolves10.1039/c1ce05778b
A kinetically controlled crystallization process for identifying new co-crystal forms: fast evaporation of solvent from solutions to dryness
resolves10.1021/cg101377u
Characterization of Carbamazepine-Nicatinamide Cocrystal Polymorphs with Rapid Heating DSC and XRPD
resolves10.1021/cg300702t
Selecting the Desired Solid Form by Membrane Crystallizers: Crystals or Cocrystals
resolves10.1021/cg801253f
Formation Kinetics and Stability of Carbamazepine−Nicotinamide Cocrystals Prepared by Mechanical Activation
resolves10.1016/j.ijpharm.2008.10.006
Particle engineering using sonocrystallization: Salbutamol sulphate for pulmonary delivery
resolves10.1021/cg034035x
Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine
resolves10.1002/anie.200603235
Screening for Inclusion Compounds and Systematic Construction of Three‐Component Solids by Liquid‐Assisted Grinding
resolves10.1021/cg801019d
Cocrystal Formation in Solution: <i>In Situ</i> Solute Concentration Monitoring of the Two Components and Kinetic Pathways
resolves10.1016/j.jcrysgro.2010.12.027
Cocrystal formation in solution: Inducing phase transition by manipulating the amount of cocrystallizing agent
resolves10.1016/j.ejpb.2006.12.016
Performance comparison of a co-crystal of carbamazepine with marketed product
resolves10.1007/s11095-006-9110-6
Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase
resolves10.1016/j.ijpharm.2012.04.027
Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph
resolves10.1007/s11095-006-9032-3
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
resolves10.1021/cg0503346
Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation
resolves10.1016/j.ejps.2009.05.010
Formation of indomethacin–saccharin cocrystals using supercritical fluid technology
resolves10.1039/c1ce05410d
Direct production of carbamazepine–saccharin cocrystals from water/ethanol solvent mixtures by membrane-based crystallization technology
resolves10.1016/j.ejpb.2006.12.002
Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy
resolves10.1002/jps.20756
Influence of Polymorphic Form, Morphology, and Excipient Interactions on the Dissolution of Carbamazepine Compacts
resolves10.1021/cg800936d
Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution
resolves10.1021/cg801261h
Crystal Engineering with Cocrystals of Benzo-[18]Crown-6 and Urea and Thiourea Derivatives
resolves10.1016/j.bmcl.2011.03.001
Simultaneous DSC-FTIR microspectroscopy used to screen and detect the co-crystal formation in real time
resolves10.1016/j.ijpharm.2012.07.038
Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals
resolves10.1081/PDT-120002234
Estimation of Initial Dissolution Rate of Drug Substance by Thermal Analysis: Application for Carbamazepine Hydrate
The 2 references without a DOI — listed, not checked
no DOI — not checkedFDA, 2011. Guidance for industry; Regulatory classification of pharmaceutical co-crystals, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
no DOI — not checkedPharmaceutical co-crystals – a review
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ijpharm.2013.04.012"><img src="https://citestamp.com/citestamped/10.1016/j.ijpharm.2013.04.012/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ijpharm.2013.04.012)